
Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia
Author(s) -
Desye Gebrie,
Tsegahun Manyazewal,
Dawit A Ejigu,
Eyasu Makonnen
Publication year - 2021
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s312997
Subject(s) - metformin , medicine , sulfonylurea , glycemic , type 2 diabetes , insulin , diabetes mellitus , type 2 diabetes mellitus , odds ratio , body mass index , endocrinology
This study aimed to compare glycemic control and risk of cardiovascular outcomes of metformin-insulin versus metformin-sulfonylurea combination therapies in type 2 diabetes mellitus.